Compare PGEN & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | PLSE |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | 2016 |
| Metric | PGEN | PLSE |
|---|---|---|
| Price | $4.43 | $15.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.67 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 3.9M | 188.7K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,309,000.00 | $86,000.00 |
| Revenue This Year | $342.78 | N/A |
| Revenue Next Year | $478.46 | $1,002.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 59.20 | N/A |
| 52 Week Low | $0.67 | $12.56 |
| 52 Week High | $5.23 | $25.00 |
| Indicator | PGEN | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 63.38 | 61.15 |
| Support Level | $3.64 | $13.94 |
| Resistance Level | $3.75 | $14.70 |
| Average True Range (ATR) | 0.26 | 0.67 |
| MACD | 0.08 | 0.28 |
| Stochastic Oscillator | 84.62 | 93.62 |
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.